1. Home
2. Resources
3. RSCNJ Fertility Blog
4. What the Trump IVF Announcement Could Mean for Fertility Patients in New Jersey

What the Trump IVF Announcement Could Mean for Fertility Patients in New Jersey

President Trump’s recent announcement on October 16, 2025, introduced new efforts to reduce the cost of fertility treatments and expand access to IVF. While the news is encouraging, the proposed changes are not yet in effect, and there’s still much we don’t know.

Key Takeaways from the Announcement

• TrumpRx Medication Discounts: A new government-backed platform is expected to offer savings on select EMD Serono medications, including Gonal-f, Ovidrel, and Cetrotide.

• Employer Fertility Coverage: Employers are being encouraged to offer fertility benefits, though there’s no requirement or federal funding attached.

• Faster Drug Approvals: The FDA will prioritize review of Pergoveris, a fertility medication not yet available in the U.S.

What’s Still to Come 

• The pricing program is not yet live and is projected to begin sometime in 2026.

• These discounts apply only to certain medications and may not benefit all patients or treatment types.

• Employer coverage remains voluntary and may vary widely by company.

Our Perspective at RSCNJ

We welcome any initiative that helps more families access the care they need. However, we also recognize that fertility is time-sensitive. Waiting for future programs could delay your best chance at success. 

For full details, visit The Prelude Network.

If you’re struggling to conceive, now is the time to speak with a fertility specialist. At RSCNJ, we offer personalized care and financial guidance to help you move forward with confidence - today.

See all articles